ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE TROPONINA I CARDÍACA (CTNI)
Mexico·Clase II·III. Agentes de diagnóstico·ABBOTT
LABORATORIES DE
MÉXICO, S.A. DE C.V.·Registered December 14, 2022- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- ALINITY I STAT HIGH SENSITIVE TROPONIN-I ASSAY
- Trade Name (English)
- ALINITY I STAT HIGH SENSITIVE TROPONIN-I ASSAY
- Analysis ID
- 1590R2022 SSA
- Registration Date
- December 14, 2022
- Name (Spanish)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
- Name (English)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE TROPONINA I CARDÍACA (CTNI) (ENSAYO PARA LA DETERMINACIÓN CUANTITATIVA DE TROPONINA I CARDÍACA (CTNI)) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1590R2022 SSA and manufactured by ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.. The device was registered on December 14, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.